Storys zum Thema Health

23.01.2012 – 11:00
Ziehm Imaging
Arizona Heart: Three advanced technology operating rooms with state-of-the art C-arm solutions / Leading hospital for heart and vascular disease opts for Ziehm Vision RFD for virtually unlimited imaging
Nuremberg (ots) - Arizona Heart, one of the area's leading hospitals for the diagnosis and treatment of heart and vascular disease, has opted for Ziehm digital flat-panel C-arms for its three advanced technology suites. The Ziehm Vision RFD hybrid edition delivers distortion-free, high-resolution images for ...
mehr
18.01.2012 – 10:03
Takeda Pharmaceutical Company Limited
Takeda Announces Strategic Measures to Achieve Efficiencies for Long-Term Growth
Osaka, Japan (ots/PRNewswire) - Takeda Pharmaceutical Company Limited announced today strategic measures to better align its global workforce and consolidate site operations in order to integrate legacy Nycomed operations, strengthen its presence in more than 70 countries, adapt to changing market conditions and maintain a focus on growth through innovation and ...
mehr
17.01.2012 – 13:55
TRON - Translational Oncology at University Medical Center Mainz
First preclinical proof-of-concept of mutation-based individualized cancer vaccine / Deep sequencing of immunogenic mutations may pave way for customized immunotherapy
Mainz (ots) - The Institute of Translational Oncology (TRON) together with BioNTech AG today announced the publication of a joint paper in the international journal Cancer Research that describes a new path for individually tailored cancer therapy. An interdisciplinary team of genome scientists and immunologists led ...
mehr
17.01.2012 – 11:45
Pevion Biotech AG
Pevion's therapeutic Candida vaccine generates functional B cell memory in all vaccinees
Ittigen, Switzerland (ots) - Pevion Biotech AG today announced further data from the ongoing clinical study of its therapeutic Candida vaccine PEV7, demonstrating the generation of specific and functional B cell memory in 100% of vaccinees. Furthermore, the results again confirm the capability of Pevion's second generation virosomal vaccine platform to induce strong ...
mehr
16.01.2012 – 08:02
Daiichi Sankyo Europe GmbH
Pan-European Stroke Prevention in Atrial Fibrillation Registry - PREFER in AF - Enrols First Patient
Munich (ots/PRNewswire) - - For European Media Only -- Collection of real life data from 5,000 atrial fibrillation patients (AF) across seven countries will generate invaluable insights into one of Europe's leading causes of stroke(1,2) -- Daiichi Sankyo Europe GmbH today announced the enrolment of the first patient ...
mehr
12.01.2012 – 08:02
Brainlab AG
Brainlab's ExacTrac® System Achieves Major Sales Milestone
Munich (ots/PRNewswire) - 500th worldwide sale highlights healthcare providers continued focus on improving care with frameless radiosurgery Today Brainlab announced the 500th sale of its ExacTrac(R) patient positioning system for frameless radiosurgery. The scale of uptake highlights physicians continued focus on adopting clinically proven systems for high-precision cancer treatments and their ongoing investment in ...
mehr

10.01.2012 – 17:37
LifeWatch AG
EANS-Adhoc: LifeWatch and Blue Shield of California sign first ever comprehensive agreement for its monitoring services (with document)
http://resources.euroadhoc.com/us/NLkgQKzC issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: ...
Ein Dokument
mehr
05.01.2012 – 01:03
European Commission
European Commission Inspires Europeans to Achieve New Year Resolution: Quitting Smoking for Good
Brussels (ots/PRNewswire) - New Year Brings New Way of Tackling Smoking for Thousands 2012 looks set to be the best year yet as the European Commission offers new thinking and support to quit smoking with their innovative campaign "Ex-Smokers are Unstoppable". A New Year is a new start - and the European Commission ...
mehr
23.12.2011 – 20:14
Ansell Healthcare nv
Ansell Limited Invests in Lakeland Industries, Inc.
Melbourne, Australia (ots/PRNewswire) - Pursuant to the filing of a Form 13D with the United States Securities and Exchange Commission, Ansell Limited (ANN.AX), a global leader in protection solutions, today announced it has made an investment in Lakeland Industries, Inc. Ansell has acquired 9.66% of the issued and outstanding shares of common stock of Lakeland Industries, Inc. . Lakeland manufactures and sells a ...
mehr
15.12.2011 – 21:18
Brainlab AG
CORRECTION - Brainlab AG: World?s First Curve(TM) Image Guided Surgery System Now Operating in Germany
Munich (ots/PRNewswire) - In the news release, "World?s First Curve(TM) Image Guided Surgery System Now Operating in Germany" issued on 15 Dec 2011 09:12 GMT, by Brainlab AG over PR Newswire, we are advised by a representative of the company that some minor changes were required to be made within the first paragraph ...
mehr
15.12.2011 – 10:15
Brainlab AG
World's First Curve(TM) Image Guided Surgery System Now Operating in Germany
Munich (ots/PRNewswire) - Highly advanced surgical navigation system to enable faster, more precise and safer surgery This week, university hospital Klinikum rechts der Isar in Munich, Germany, is the first hospital in the world to operate with Brainlab's Curve(TM) Image Guided Surgery system. The new technology is hoped to provide surgeons with the best possible ...
mehr
14.12.2011 – 07:02
Cryo-Save AG
A New International Congress on Regenerative Medicine Held With Great Success by Cryo-Save in Bosnia
Zutphen, The Netherlands (ots/PRNewswire) - It is part of Cryo-Save's educational program deployment to increase the awareness of stem cells therapy and regenerative medicine amongst healthcare professionals. The Second international congress "Regenerative medicine - stem cells, genetic engineering and ...
mehr

13.12.2011 – 17:38
LifeWatch AG
EANS-Adhoc: LifeWatch and Tracker to launch LifeTracker in Switzerland. LifeTracker Mobile phone including medical consultation service for target group 55+. (with document)
http://resources.euroadhoc.com/us/rmvkjJOh issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: ...
Ein Dokument
mehr
13.12.2011 – 08:02
Daiichi Sankyo Europe GmbH
Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery
Munich (ots/PRNewswire) - Pooled results of the STARS E-III and STARS J-V studies presented at the 2011 American Society of Hematology (ASH) Annual Meeting Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced the results of a pooled analysis showing that edoxaban*, a direct oral once-daily ...
mehr
09.12.2011 – 07:00
Sequana Medical AG
NHS National Innovation Centre estimates Sequana Medical's ALFApump® System could save the NHS £50 million in ascites care annually
Zurich, Switzerland (ots) - NHS National Innovation Centre supports the cost effectiveness of Sequana Medical's ALFApump System Sequana Medical announced today the findings of an independent economic assessment of the ALFApump System commissioned by the National Innovation Centre, the NHS organization which supports ...
mehr
08.12.2011 – 16:23
Takeda Pharmaceutical Company Limited
Takeda's Edarbi® (azilsartan medoxomil) Receives European Marketing Authorisation for the Treatment of Essential Hypertension
London and Osaka, Japan (ots/PRNewswire) - Takeda Pharmaceutical Company Limited (Takeda) today announced that the European Commission has granted marketing authorisation for Edarbi(R) (azilsartan medoxomil), a new once-daily angiotensin receptor blocker (ARB) (also known as angiotensin II receptor antagonist ...
mehr
05.12.2011 – 14:13
sanofi-aventis Group
Impact of Early Insulin Initiation on Glycemic Control in Asian People with Type 2 Diabetes
Paris (ots/PRNewswire) - Two studies presented at World Diabetes Congress 2011 provide further evidence of the benefits to patients of early glycemic control on co-morbidities Sanofi announced today new results from sub-analyses of the First Basal INsulin Evaluation in Asia (FINE Asia) Registry study,[1] and the Cardiovascular Risk Evaluation in People with Type 2 ...
mehr
30.11.2011 – 09:03
Hansen Medical, Inc
Hansen Medical Announces Worldwide Survey of AF Ablation with Robotic Navigation Presented at American Heart Association Meeting
London, November 30 (ots/PRNewswire) - Multi-Center Procedure Data Presented in Over 1700 Cases Using the Sensei(R) X Robotic Catheter System Hansen Medical, UK Ltd, a subsidiary of Hansen Medical, Inc., , a global leader in flexible robotics and the developer of robotic technology for accurate 3D control of ...
mehr

29.11.2011 – 09:24
Bristol-Myers Squibb and AstraZeneca
KOMBOGLYZE(TM) Receives Marketing Authorisation in the European Union for Adult Patients With Type 2 Diabetes
Paris and London, November 29 (ots/PRNewswire) - Bristol-Myers Squibb Company and AstraZeneca announced today that the European Commission has granted marketing authorisation for KOMBOGLYZETM (saxagliptin and metformin HCl immediate-release fixed dose combination) that will cover the 27 Member States of the European ...
mehr
28.11.2011 – 08:03
Ansell Healthcare nv
Ansell Limited Acquires a Minority Share in Yulex Corporation
Melbourne, Australia, November 28 (ots/PRNewswire) - Ansell Limited (ANN.AX), a global leader in protection solutions, today announced it has purchased a minority share of Yulex Corporation, a manufacturer of biopolymers derived from guayule. The investment is not expected to have any material impact on Ansell's earnings per share in Fiscal Years 2012 and 2013. Further, Ansell and Yulex executed an exclusive agreement for ...
mehr
25.11.2011 – 17:53
Bristol-Myers Squibb GmbH & Co. KGaA
European Commission Approves Labelling Update for REYATAZ® (atazanavir sulfate) in Pregnant Women Living With HIV
Paris, November 25 (ots/PRNewswire) - - REYATAZ(R) is the only boosted PI to include dosing and medical guidance in pregnancy and postpartum in the label - Bristol-Myers Squibb Company today announced that the European Commission approved a labelling update for REYATAZ(R) (atazanavir sulfate) based on new data ...
mehr
23.11.2011 – 17:57
LifeWatch AG
EANS-Adhoc: LIFEWATCH AND TRACKER ANNOUNCE JOINT-VENTURE. LifeWatch products now also available in Switzerland. (with document)
http://resources.euroadhoc.com/us/BdZOgnI9 issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: ...
Ein Dokument
mehr
22.11.2011 – 07:03
Cryo-Save AG
Cryo-Save is Proud to Announce the Achievement of 200,000 Samples Stored From Umbilical Cord Blood and Umbilical Cord Tissue
Zutphen, the Netherlands, November 22 (ots/PRNewswire) - This landmark storage of the 200,000th stem cell sample indicates a step forward in Cryo-Save's leading role in the cord blood industry Cryo-Save is proud to announce the storage of its 200,000th sample. This great achievement shows the successful results of ...
mehr
21.11.2011 – 09:03
Anteis
FDA Approves BELOTERO Balance®: Success of a Promising Partnership Between Anteis and Merz Aesthetics
GENEVA and PLAN- LES-OUATES, Switzerland, November 21, 2011 (ots/PRNewswire) -- BELOTERO Balance(R) has now been approved by the US Food and Drug Administration (FDA) for injection into the mid-to-deep dermis to correct moderate-to-severe facial wrinkles and folds such as nasolabial folds. BELOTERO Balance(R) is a hyaluronic acid-based cohesive gel dermal filler that ...
mehr

18.11.2011 – 12:33
AstraZeneca GmbH
CAPRELSA? (vandetanib) Receives Positive CHMP Opinion in the European Union for Treating Advanced Medullary Thyroid Cancer
London, November 18 (ots/PRNewswire) - AstraZeneca today announced that the Marketing Authorisation Application for CAPRELSA (vandetanib) received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for the treatment of aggressive and symptomatic medullary thyroid cancer (MTC) in ...
mehr
16.11.2011 – 15:04
Sunshine Biopharma Inc.
Sunshine Biopharma Announces Successful Completion of Preclinical Studies for Adva-27a, the Company's Lead Anti-Cancer Compound
Montreal, November 16 (ots/PRNewswire) - Sunshine Biopharma Inc. a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has successfully completed the preclinical studies for Adva-27a, the ...
mehr
15.11.2011 – 21:43
EvaluatePharma Ltd
Linking EudraCT and ClinicalTrials.gov Records Provides Huge Benefit
London, November 15 (ots/PRNewswire) - EvaluatePharma Ltd, a leading source for life science sector analysis and the first to supply consensus forecasts of global drug sales, announced today the launch of its new clinical trial intelligence service, EP Clinical Trials [http://www.evaluatepharma.com/clinical ][SM]. By linking EudraCT [https://eudract.ema.europa.eu ] and ...
mehr
15.11.2011 – 12:28
Ansell Healthcare nv
Ansell HyFlex® Glove Range Reaches 500 Million Pairs in Sales
RED BANK, New Jersey, MELBOURNE, Australia, and BRUSSELS, November 15, 2011 (ots/PRNewswire) -- In just 15 years, Ansell's best-selling brand sells 500M pairs worldwide Ansell, global leader in health and safety solutions with over a century of expertise, has today reached a historic milestone - the sale of its 500 millionth pair of HyFlex(R) gloves. Since its creation, the HyFlex [http://www.ansell.com/corporate/ ...
mehr
15.11.2011 – 08:02
Boston Scientific
Boston Scientific Begins Marketing Remote Catheter System in Europe Through Exclusive Agreement With Catheter Robotics
Paris, November 15 (ots/PRNewswire) - CRI's Amigo(TM) system allows remote control of Boston Scientific's leading cardiac ablation catheters Boston Scientific Corporation is beginning to market the CRI Amigo(TM) system, a remote-controlled catheter system, and related accessories in select European countries through ...
mehr
09.11.2011 – 07:03
Boston Scientific
Boston Scientific CRE? Wireguided Balloon Dilator CE Marked for Expanded Indication
Paris, November 9 (ots/PRNewswire) - Now available for endoscopic dilation of the Sphincter of Oddi following sphincterotomy Boston Scientific Corporation's CRE(TM) Wireguided Balloon Dilator is now CE marked for endoscopic dilation of the Sphincter of Oddi following sphincterotomy. The new indication, which supplements the product's current indication for use in the ...
mehr

Vorherige57585960616263646566Nächste